Literature DB >> 23293791

Antiretroviral preexposure prophylaxis for HIV prevention.

Jared M Baeten, Connie Celum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23293791     DOI： 10.1056/NEJMc1210464

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

1.  "I Did Not Want to Give Birth to a Child Who has HIV": Experiences Using PrEP During Pregnancy Among HIV-Uninfected Kenyan Women in HIV-Serodiscordant Couples.

Authors:  Jillian Pintye; Kristin M Beima-Sofie; Grace Kimemia; Kenneth Ngure; Susan Brown Trinidad; Renee A Heffron; Jared M Baeten; Josephine Odoyo; Nelly Mugo; Elizabeth A Bukusi; Maureen C Kelley; Grace C John-Stewart
Journal:  J Acquir Immune Defic Syndr       Date:  2017-11-01       Impact factor: 3.731

2.  Contraceptive method switching among women living in sub-Saharan Africa participating in an HIV-1 prevention trial: a prospective cohort study.

Authors:  Catherine A Chappell; Ishana Harkoo; Daniel W Szydlo; Katherine E Bunge; Devika Singh; Clemensia Nakabiito; Felix Mhlanga; Betty Kamira; Jeanna M Piper; Jennifer E Balkus; Sharon L Hillier
Journal:  Contraception       Date:  2019-06-19       Impact factor: 3.375

Review 3.  Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs: State of Research and Future Directions.

Authors:  Kimberly Page; Judith Tsui; Lisa Maher; Kachit Choopanya; Suphak Vanichseni; Philip A Mock; Connie Celum; Michael Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

4.  Brief Report: Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017).

Authors:  Albert Y Liu; Aliza Norwood; Holly Gundacker; Alex Carballo-Diéguez; Sherri Johnson; Karen Patterson; Linda-Gail Bekker; Suwat Chariyalertsak; Anupong Chitwarakorn; Pedro Gonzales; Timothy H Holtz; Kenneth H Mayer; Carmen Zorrilla; Susan Buchbinder; Jeanna M Piper; Javier R Lama; Ross D Cranston
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-15       Impact factor: 3.731

5.  Editorial Commentary: Can We Afford to Control the HIV Epidemic With Antiretrovirals? Can We Afford Not to Do So?

Authors:  Kenneth H Mayer; Douglas S Krakower
Journal:  Clin Infect Dis       Date:  2016-08-23       Impact factor: 9.079

6.  Renal Function and Tenofovir Disoproxil Fumarate for Preexposure Prophylaxis: How Safe Is Safe Enough?

Authors:  Douglas S Krakower; Kenneth H Mayer
Journal:  J Infect Dis       Date:  2016-04-27       Impact factor: 5.226

7.  Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048.

Authors:  Albert Y Liu; Jingyang Zhang; Peter L Anderson; Theresa Wagner; Zhenyu Pan; Melissa Peda; Kailazarid Gomez; May Beamer; Cindy Jacobson; Julie Strizki; Charlene S Dezzutti; Jeanna M Piper
Journal:  Clin Infect Dis       Date:  2019-03-19       Impact factor: 9.079

Review 8.  Gonadal function and reproductive health in women with human immunodeficiency virus infection.

Authors:  Swaytha Yalamanchi; Adrian Dobs; Ruth M Greenblatt
Journal:  Endocrinol Metab Clin North Am       Date:  2014-09       Impact factor: 4.741

9.  Preferences for HIV pre-exposure prophylaxis (PrEP) information among men-who-have-sex-with-men (MSM) at community outreach settings.

Authors:  Roland C Merchant; David Corner; Eduardo Garza; Wentao Guan; Kenneth H Mayer; Larry Brown; Philip A Chan
Journal:  J Gay Lesbian Ment Health       Date:  2015-10-27

10.  Examining the Potential of Pre-exposure Prophylaxis (PrEP) for HIV Prevention in a Community Sample of Persons Who Use Stimulants Living in the Southern United States.

Authors:  Sheri L Towe; Catherine A Sullivan; Mehri S McKellar; Christina S Meade
Journal:  AIDS Behav       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.